Sepha shows off BlisterScan in Japan
Northern Irish pack testing specialist Sepha has moved forward with plans to enter the Japanese market, showcasing its BlisterScan platform at Interphex Japan in Tokyo last week.
Charles River rejigs exec roles and preclinical organisation
US CRO Charles River (CRL) has unveiled a raft of executive changes and plans to restructure its PCS unit to provide customers with a more centralised approach to global drug development.
Chiltern sets up in Hungary
UK group Chiltern International has opened an office in Budapest Hungary, joining the growing number of CRO players to set up in the CEE.
Originates increases pharma gelatin capacity
US raw materials supplier Originates has boosted its pharmaceutical bovine hide gelatin manufacturing capacity with the addition of two new ISO 9000/9001 certified, GMP-standard production facilities in South America.
Synteract sets up in Czech Republic joining CRO CEE rush
Synteract will open an office in Prague in the Czech Republic, joining the growing number of CROs to offer sponsors access to treatment naive populations in Central and Eastern Europe (CEE).
Quintiles sets up in Ghana to boost recruitment pool
UK CRO Quintiles Transnational has set up an office in Accra, Ghana in a move it claims allows it to recruit trial participants from sub-Saharan Africa’s estimated 760m residents.
Large pharmas turning to 3PL to cut costs
Large pharma companies will increase the level of supply chain activities they outsource in the next few years but smaller businesses are predicted to keep them in-house, according to a report.
DZS rolls out ClinPlus CTMS for complex trials
US group DZS Software Solutions says its new web ClinPlus CTMS technology will help sponsors and CROs ensure that trial procedures are being followed and eliminate redundant study management systems.
Biologics contracting worth $2.6bn this year, says HiTec
Demand for biopharmaceutical contract manufacturing will grow 16 per cent a year over the next five years, according to analysis by US market research group HighTech Business Decisions.
CBI targets “boom” in peptide outsourcing market
Commonwealth Biotechnologies (CBI) is set to acquire China-based peptide manufacturer GL Biochem, which it believes will create a dominant force in the non-GMP segment of the market.
Syntagon “cuts out middlemen” with China office
Swedish CRO Syntagon has set up an office in Shanghai, China to forge stronger links with a broader range of local raw materials suppliers, saving its customers time and money.
Kemwell & Boehringer collaborate on biologics
CMO Kemwell is receiving technical assistance from Boehringer Ingelheim for the construction of its new biotech facility, which is designed to marry European technology with Indian low cost manufacturing.
MDS expands Taiwan capacity in early stage focus
MDS Pharma Services is renovating and expanding its Taiwanese discovery pharmacology operation in response to growing global demand for work performed in Asia.
GE unveils modular approach to facility validation
GE Healthcare hopes its new modular validation platform (MVP) will change the way drugmakers think about how they create new plants and bring existing manufacturing facilities up to code.
Kendle further expands Asia-Pacific presence
US CRO Kendle has set up three units in Malaysia, Thailand and the Philippines, further demonstrating the growing importance of the Asia Pacific for the contract research sector.